Coronavirus: inside the ‘scrambled’ UK deal for five million Moderna vaccines
Fears over Trump’s ‘vaccine nationalism’ and European supplies led British ministers to prioritise other agreements

As news of another vaccine breakthrough emerged yesterday morning, ministers and civil servants rushed to finalise a deal to buy five million doses - at a cost of £95m.
Although the UK has secured 350 million doses of six Covid-19 jabs, most of which are still undergoing trials, “the Moderna vaccine is not one of those which the government has pre-ordered”, says The Spectator.
The reason, says The Times, is that “large-scale production of the Moderna vaccine is not expected in Europe until April”. As a result, “reaching agreement with other companies that can manufacture more rapidly was prioritised in the hope of starting mass immunisation before the year’s end”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A reluctance to deal with a US company amid “vaccine nationalism” and “concerns over unpredictable behaviour by the US president” also played a part, The Guardian reports. Ministers were reportedly concerned that Donald Trump might commandeer injections before they could be sent to the UK.
Finally, says Politico, the government “wanted to see the Phase 3 results before agreeing a deal”. When those results suggested that the vaccine was 95% effective, ministers and officials “hit Zoom and rushed through an agreement with Moderna”.
The last-minute response had led to “fears that Britain had missed out on supplies”, says The Guardian, especially as “the UK had also shunned the EU vaccine purchase scheme, arguing in July that the government could source vaccines faster on its own”.
That confidence appeared to be justified yesterday, when EU health commissioner Stella Kyriakides said she had “not yet concluded or signed a contract” with Moderna, although “negotiations with the company are ongoing”.
Aside from the Moderna jab, the UK has ordered 40 million doses of the 90% effective Pfizer/BioNTech vaccine - and 100 million doses of the Oxford/AstraZeneca vaccine candidate, which is still in Phase 3 trials.
Ministers “remain hopeful” that the Oxford jab “could be available soon - even by Christmas - with results of that trial reported to be imminent”, says The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Today's political cartoons - March 29, 2025
Cartoons Saturday's cartoons - my way or Norway, running orders, and more
By The Week US Published
-
5 tactically sound cartoons about the leaked Signal chat
Cartoons Artists take on the clown signal, baby steps, and more
By The Week US Published
-
Roast lamb shoulder with ginger and fresh turmeric recipe
The Week Recommends Succulent and tender and falls off the bone with ease
By The Week UK Published
-
'There is a certain kind of strength in refusing to concede error'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published
-
'A political agenda aimed at reshaping higher education into an ideological stronghold'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published
-
'Most Americans have never heard of the Office of Net Assessment'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Trump pulls nomination of anti-vax CDC pick
Speed Read Former Florida congressmen Dr. Dave Weldon was nominated to lead the Centers for Disease Control and Prevention
By Rafi Schwartz, The Week US Published
-
Has Starmer put Britain back on the world stage?
Talking Point UK takes leading role in Europe on Ukraine and Starmer praised as credible 'bridge' with the US under Trump
By Harriet Marsden, The Week UK Published
-
Measles: Kennedy’s big disease test
Feature Texas reports over 120 measles cases, the highest in 30 years
By The Week US Published
-
'Failure to vaccinate against these diseases is dangerous to your child'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
'What Americans really need is access to safer products'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published